Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Silverback Therapeutics
Curegenix Inc.
Curegenix Inc.
Hangzhou Converd Co., Ltd.
University of Nottingham
Technical University of Munich
Shandong University
Poniard Pharmaceuticals
National Cancer Center, Korea